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cedes properdin in the reaction sequence 
[l] (Fig. I). Thus, the initiating factor 
could be the analogue of C 1, and the neph- 
ritic factor may be the activated form. 
A third pathway has been described 
which is initiated by antibody mediated 
activation of Cl and which utilizes com- 
ponents of the previously described 
alternative pathway. This proposed third 
pathway by-passes the use of C4 and C2 
to activate C3-9 [26]. 
The attack of C5 by the C5 convertases 
derived from either the classical or alterna- 
tive pathways initiates the self-assembly 
process which, without further enzymic 
action, results in the production of the 
stable C5b-9 complex (thought to be com- 
posed of equimolar amounts of C5b, C6, 
C7, and C8 and six times as much C9) 
[l]. Theories proposing that the entire 
C5b-9 complex is either inserted into the 
membrane or that a small portion of the 
complex is extended through the mem- 
brane to allow exchange of intra- and 
extracellular constituents by means of in- 
ternal hydrophilic channels have been put 
forward to explain the lysis of cells by com- 
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Ascorbic acid and 
drug detoxification 
V. G. Zannoni and L. E. Rikans 
Ascorbic acidplays apart in maintaining adequate drug detoxification and its- biochemical 
mode ofaction is of current interest. 
It has been shown by both in vivo and 
in vitro experiments that vitamin C deli- 
ciency in guinea pigs results in decreased 
metabolism of a variety of drugs, steroids 
and cholesterol and that high supplements 
of the vitamin augment the activity of 
the drug enzyme system [l-5]. Our current 
knowledge of the liver microsomal path- 
way involved in the metabolism of many 
pharmacological agents is shown in Fig. 
1. It involves an important heme protein, 
Department of Pharmacology, the University of Michi- 
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U.S.A. 
cytochrome P-450, which is reduced by Specificity studies with other reducing 
NADPH via a flavoprotein, cytochrome agents used in place of ascorbic acid in 
P-450 reductase. For oxidative metabolic vivo, such as reduced 2,6-dichlorophenol- 
reactions the heme protein in its reduced indophenol dye, reduced glutathione, and 
state (Fe*+) incorporates one atom of D-isoascorbic acid, indicated that the vita- 
oxygen into the drug substrate and another min is relatively specific in that these 
into water. Many metabolic reductive reducing agents did not significantly affect 
reactions also utilize the hepatic cytoch- the levels of cytochrome P-450, NADPH 
rome P-450 microsomal system. Asso- cytochrome P-450 reductase orp-nitroani- 
ciated with this important electron trans- sole 0-demethylation [ 151. Reversals of 
port system is a lipid component, namely, decreased drug metabolism activities in 
phosphatidyl choline. Importantly, the vitamin C deficient animals by the in vivo 
hepatic drug metabolizing system is in- administration of ascorbic acid showed 
fluenced by physiological and environ- that, although the quantity of liver ascor- 
mental factors which can affect the extent 
ofdetoxification [6]. For example, the acti- 
vity of the microsomal system is markedly 
increased with chronic exposure to a great 
variety of agents such as barbiturates, car- 
cinogens and environmental chemicals 
[7]. This induction is a type of drug-drug 
interaction in which a drug can cause an 
increase in its own metabolism as well as 
the metabolism of other drugs. It is 
obvious that ascorbic acid could partici- 
pate at a variety of levels in this compli- 
cated hepatic microsomal system, and a 
number of laboratories have contributed 
to the elucidation of the biochemical basis 
for the vitamin’s participation [3-5,8-141. 
Vitamin C deficient diet 
Adult guinea pigs maintained on a vita- 
min C deficient diet for 21 days had de- 
creased overall drug metabolism, such as 
aniline hydroxylation, aminopyrine N- 
demethylation and p-niiroanisole O- 
demethylation, as well as decreased quan- 
tities of cytochrome P-450 and cytochrome 
P-450 reductase. The liver microsomal 
ascorbic acid was about 40% of normal; 
the animals had lost, at most, 5 % of their 
body weight and frankly were not scorbu- 
tic [l I]. In addition, weanling guinea pigs 
(90-11Og and 1-2 weeks of age) placed 
on a vitamin C deficient diet for a relatively 
short period (8-15 days) also showed a 
decrease in drug metabolism activity and, 
when given high supplements of vitamin 
C, showed substantial increases in overall 
drug metabolism activity and quantity of 
electron transport components (Table I). 
Furthermore, fetal guinea pig livers 
showed a marked variation in cytochrome 
P-450 and 0-demethylase activity which 
correlated well with the concentration of 
liver ascorbic acid [15]. Fetal livers with 
an ascorbic acid concentration of below 
5.0 mg/lOO g liver had no detectable 
cytochrome P-450 or 0-demethylase acti- 
vity while livers with high ascorbic acid 
levels (above 17.0 mg/lOO g liver) had 
much higher drug metabolism activity; 
cytochrome P-450 concentration was 84 % 
of the dams while 0-demethylase activity 
was 51% of the control dams. 
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bit acid was restored to normal levels 
within three days, most of the drug enzyme 
activities required 610 days of ascorbic 
acid administration to reach normal levels 
[ 111. Other studies using phenobarbital in- 
dicated that protein synthesis is operable 
in vitamin C deficiency in that overall drug 
oxidation activities (aniline hydroxylase, 
aminopyrine N-demethylase, and p- 
nitroanisole 0-demethylase) and microso- 
ma1 electron transport components were 
induced in vitamin C deficient guinea pigs 
comparable to the extent of induction in 
normal animals. 
Glycine + succinyl CoA sy”thetase b 
,j_aminolevuCnic aciddehyd’“‘““e + 
porphobilinogen++ 
protoporphorin IX f’rrochz’ata’e > 
heme+apoprotein+cytochrome P-450. 
Experiments were carried out to deter- 
It would be of interest to determine if 
there are any differences in ferrochelatase 
activity, since iron must be maintained in 
its ferrous state for incorporation into pro- 
toporphorin IX, and ascorbic acid could 
be involved at this level [ 191. Furthermore, 
it will be of importance to examine degra- 
dation ofcytochrome P-450, since a reduc- 
tion of P-450 levels in ascorbic acid defi- 
ciency could also be due to an increased 
breakdown of the cytochrome. 
Physical differences in microsomes 
Kinetic studies with 0-demethylase in- 
dicate no significant difference in the 
apparent affinity of p-nitrolnisole in nor- 
mal (L= 5.40 x 10W4 M), ascorbic acid 
deficient (K,=4.43 x 10e4 M) or animals 
given high supplements of the vitamin 
(K,=4.35 x 10M4 M). In addition, no 
significant differences were found in K, 
mine if vitamin C deficiency affected the 
activity of &aminolevulinic acid synthe- 
tase, the rate-limiting enzyme in heme syn- 
thesis as well as S-aminolevulinic acid 
dehydratase, _the enzyme involved in the 
condensation of &aminolevulinic acid to 
porphobilinogen [ 181. Synthetase activity 
in liver homogenates from weanling 
guinea pigs placed on a vitamin C deficient 
diet for l&18 days did not differ signifi- 
cantly from the activity from control 
guinea pigs given daily supplements of 
vitamin C in their drinking water 
(1 mg/ml). In addition, there were no signi- 
ficant differences in the &aminolevulinic 
acid dehydratase activities. 
TABLE I 
In contrast to the above results some 
differences in physical chemistry have been 
observed in microsomes prepared from 
deficient and normal animals. For exam- 
ple, cytochrome P-450 prepared from 
ascorbic acid deficient livers is less stable 
to sonication, dialysis, and treatment with 
metal chelators. The decrease in cytoch- 
rome P-450 and 0-demethylase activity 
associated with dialysis could be prevented 
by the addition of ascorbic acid [14,16]. 
Results from several different kinds of stu- 
dies indicate that ascorbic acid may be clo- 
sely associated with cytochrome P-450. 
The molar ratio of microsomal ascorbic 
acid to cytochrome P-450 was found to 
be in the order of 1: 1, and this ratio was 
maintained during ascorbic acid deficiency 
in liver and adrenal tissue, during dialysis, 
on storage, and during partial purification 
of the cytochrome. In addition, ascorbic 
acid protects cytochrome P-450 and 
aniline hydroxylase activity from inhibi- 
tion by ferrous iron chelators such as a,a’- 
dipyridyl. The chelator reacts with cytoch- 
rome P-450 and prevents the formation 
of the reduced cytochrome P-45&CO 
spectrum. a,a’-Dipyridyl, in turn, gives a 
spectrum with the cytochrome at 450 nm, 
and ascorbic acid protects the cytochrome 
The effect of in viva administration of ascorbic acid on drug metabolism in weanling guinea pigs. 
Treatment Ascorbic acid P-450 P-450 p-Nitroanisole Aminopyrine 
reductase O-demethylase N-demethylase 
Chow (5) 
Ascorbate 
(25 mg) (6) 
Ascorbate 
(7 mg) (5) 
Deficient diet 
(l5-day) (6) 
21 0.068 +0.002 10.2 kO.7 10.5+ I.0 l5.7kO.4 
8 0.060 + 0.004 7.5 +0.8 8.0 +O.S 15.9t2.3 
6 0.060 +0.004 7.0 +0.8 7.5 kO.5 14. I f 0.9 
< I.0 0.047 +0.002 3.4 +0.4 2.6 kO.2 10.0 f0.8 
Weanling male albino guinea pigs, Hartley strain, were placed on various diet regimens as given in 
the table. Initial body weight of the animals ranged from I10 to 120 g. The body weights of animals 
on the ascorbic acid deficient diet did not differ significantly from the other groups. Groups of animals 
given the deficient diet were supplemented with either 25 or 7 mg of ascorbic acid given orally each day 
for I5 days. The number in parentheses equals number of animals in each group. 
The concentration of ascorbic acid is given as mg/lOO g liver; cytochrome P-451! equals Itmoles/ 
100 mg microsomal protein; cytochrome P-450 reductase activity equals pmoles P-450 reduced per hr per 
100 mg microsomal protein at 27”; O-demethylase activity equals p-nitrophenol formed per hr per 100 mg 
microsomal protein at 27”; N-demethylase activity equals pmoles formaldehyde formed per hr per 100 mg 
microsomal protein at 27’. Values are given as the mean &SE. 
constants with aminopyrine N-demethy- 
lase in these groups [4]. Furthermore, the 
decrease in drug metabolism caused by 
ascorbic acid deficiency was not due to 
increased lipid peroxidation nor was there 
a significant qualitative or quantitative 
alteration in the important microsomal 
phospholipid component, phosphatidyl 
choline [ 141. 
Impairment of heme synthesis 
The possibility that the decreased ,quan- 
tity of cytochrome P-450 in ascorbic acid 
deficient microsomes may result from an 
impairment in heme synthesis was investi- 
gated. It was found that cytochrome P- 
450 levels returned to normal when scor- 
butic guinea pigs were injected with 6- 
aminolevulinic acid, a key substrate for 
heme biosynthesis [17]. A general scheme 
for the synthesis of heme is indicated 
below. 
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from interaction with the chelator. The 
formation of a CO ligand with reduced 
cytochrome P-450 is the basis of determin- 
ing the quantity of heme protein in the 
microsomes (Fig. 1). These studies suggest 
that there is an interaction between ascor- 
bic acid and cytochrome P-450, involving 
the reduced form of the heme iron [ 14,161. 
Brown fat mitochondria 
David G. -Nicholls 
The need for vitamin C in the detoxitica- 
tion of drugs in humans may be important, 
especially during growth. In addition, the 
possibility should be considered that those 
individuals with insufficient intake of vita- 
min C may show sensitivity and possible 
toxicity to drugs. This would be true, for 
example, if increased formation of meta- 
bolites is necessary to ensure adequate 
detoxification. Of interest would be the 
time required for humans on a low intake 
ofvitamin C to re-establish sufficient levels 
of drug metabolism after supplementation 
with the vitamin. In this respect increasing 
the intake of ascorbic acid in man above 
the recommended allowance (70-75 mg 
per day) to observe the effect on the bio- 
logical plasma half-life of a variety of 
drugs as well as steroids and cholesterol 
may be of clinical importance. 
Browx fit mitochondriu can short-circuit their respiratory chain to generate heat. 
Our normal response to cold is to shiver. 
Shivering is caused by small muscular con- 
tractions which dissipate metabolic energy 
as heat and so help to restore our body 
temperature. There is, however, an 
alternative mens of generating heat under 
certain conditions which has .been termed 
‘non-shivering thermogenesis’, and which 
is important at birth, when an immense 
cold-shock must be overcome very rapidly, 
as well as being vital for the cold-adapta- 
tion of a variety of small mammals. Non- 
shivering thermogenesis is, in addition, an 
essential mechanism for hibernators, as 
heat can be generated even when the ani- 
mal’s body temperature is very low, and 
thus prevent the animal from literally 
freezing. 
attempting to restore the cytoplasmic ATP 
levels which were lowered by the ATPase 
action of the muscle. In brown fat, how- 
ever, no such potent ATP-hydrolysing sys- 
tem can be found to account for the very 
high rates of respiration of which the tissue 
is capable [24]. If no way exists of hydro- 
lysing ATP at a sufficient rate, then it fol- 
lows that little ATP can be synthesized 
in the first place; in other words that brown 
fat mitochondria can uncouple the oxida- 
tion of fatty acids from the production 
of ATP. The isolated mitochondria have 
therefore been studied intensively in an 
attempt to localize the molecular nature 
of this ‘uncoupling’ (for reviews, see [24]). 
The proton circuit 
References 
The most important site of non-shiver- 
ing thermogenesis is in brown fat, a tissue 
which appears to be specialized solely for 
heat production. The tissue is perfectly 
adapted to its role. It can increase live-fold 
in weight on cold-adaptation, and has an 
ingenious blood supply which is directed 
towards warming the vital organs and 
which also involves a system of counter- 
current heating to ensure that blood enter- 
ing the tissue is as warm as possible [1,2]. 
The cells contain many triglyceride drop- 
lets, and most of the remaining cytoplasm 
is packed with highly active mitochondria 
[2]. The tissue is controlled by the sympa- 
thetic nervous system which has norad- 
renalin-containing synapses in contact 
with thecells [2]. Release of the transmitter 
activates cyclic AMP production, which 
in turn activates a lipase, releasing free 
fatty acids as substrate for the mitochon- 
‘dria. The way in which brown fat mito- 
chondria are adapted to handle this ter- 
minal oxidation is the subject of this arti- 
cle. 
The chemiosmotic theory of Mitchell 
[5,6] provides a framework within which 
to investigate such physiological uncou- 
pling. The proton circuit, the essence of 
the theory, is shown on p. 129. Substrate 
oxidation by the respiratory chain is linked 
to the expulsion of protons from the mito- 
chondrial matrix, leading to the build-up 
of a proton electrochemical gradient (or 
protonmotive force) across the membrane 
which is analogous to the voltage 
developed by a battery, and is usually 
expressed in millivolts. Just as an electrical 
circuit requires a continuous pathway of 
electron conductors for current to flow, 
in the same way the proton circuit must 
be completed by some pathway that con- 
ducts protons back through the inner 
membrane. In most mitochondria the pre- 
dominant pathway of proton re-entry is 
via the ATPase, the drop in potential of 
the protons being used to drive the energe- 
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Physiological ‘uncoupling’? 
Mitochondria normally function to 
minimize the dissipation of chemical 
energy as heat, and one way that this is 
achieved is by a tight coupling of respira- 
tion to ATP production. For example, the 
high respiratory rate of exercising muscle 
is a consequence of the mitochondria 
Department qf Psychiatry, University of Dundee. 
Ninewells Medical School, Dundee, Scotland, U.K. 
Mitchell proposed [5,6] that not only 
was respiration tightly linked to the expul- 
sion of protons, but also that proton re- 
entry was tightly linked to the production 
of ATP, so that when the cell had no 
further need for ATP synthesis, the proton 
current through the ATPase stopped, with 
the result that the proton electrochemical 
gradient built up, stopping further proton 
release (and hence respiration) by the 
respiratory chain. Clearly this automatic 
respiratory control could be overcome in 
two ways: if the link between respiration 
and proton extrusion could be broken, or 
if a way could be found of allowing pro- 
